Which of the following is an appropriate use of CA 19- 9?
(A) Screening normal, healthy patients for pancreatic cancer
(B) Screening at-risk patients for pancreatic cancer
(C) Confirming diagnosis of pancreatic cancer in patients with periampullary mass on CT
(D) Monitor for progression of disease following resection and/ or adjuvant therapy
(E) None of the above